Best Practice & Research Clinical Rheumatology
Volume 22, Issue 5 , Pages 923-935 , October 2008

Smoking and inflammatory diseases

References 

  1. MacGregor AJ, Snieder H, Rigby AS, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis and Rheumatism. 2000;43:30–37
  2. Jawaheer D, Gregersen PK. Rheumatoid arthritis. The genetic components. Rheumatic Diseases Clinics of North America. 2002;28:1–15
  3. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism. 1988;31:315–324
  4. Reckner-Olsson A, Skogh T, Wingren G. Comorbidity and lifestyle, reproductive factors and environmental exposures associated with rheumatoïd arthritis. Annals of the Rheumatic Diseases. 2001;60:934–939
  5. Krishnan E, Sokka T, Hannonen P. Smoking-gender interaction and risk for rheumatoid arthritis. Arthritis Research & Therapy. 2003;5:158–162
  6. Criswell LA, Merlino LA, Cerhan JR, et al. Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: results from the Iowa Women's Health Study. The American Journal of Medicine. 2002;112:465–471
  7. Karlson EW, Lee IM, Cook NR, et al. A retrospective cohort study of cigarette smoking and risk of rheumatod arthritis in female health professionals. Arthritis and Rheumatism. 1999;42:910–917
  8. Costenbader KH, Feskanich D, Mandl LA, Karlson WK. Smoking intensity, duration and cessation and the risk of rheumatoid arthritis in women. The American Journal of Medicine. 2006;119:503–511
  9. Stolt P, Bengtsson C, Nordmark B, et al. and the other members of the EIRA study group Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study using incident cases. Annals of the Rheumatic Diseases. 2003;62:835–841
  10. Mattey DL, Dawes PT, Clarke S, et al. Relationship among the HLA-DRB1 shared epitope, smoking and rheumatoid factor production in rheumatoid arthritis. Arthritis and Rheumatism. 2002;47:403–407
  11. Lee HS, Irigoyen P, Kern M, et al. Interaction between smoking, the shared epitope and anti-cyclic citrullinated peptide. A mixed picture in three large north American rheumatoid arthritis cohorts. Arthritis and Rheumatism. 2007;56:1745–1753
  12. Pedersen M, Jacobsen S, Klarlund M, et al. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthritis Research & Therapy. 2006;8:R133
  13. Klareskog L, Stolt P, Landberg K, et al. A new model for an etiology of rheumatoid arthritis. Smoking may trigger HLA-DR (Shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis and Rheumatism. 2006;54:38–46
  14. Michou L, Teixeira VH, Pierlot C, et al. Association between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis. Annals of the Rheumatic Diseases. 2008;67:466–470
  15. Lee DM, Phillips R, Hagan EM, et al. Quantifying anti-CCP titer: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. April 2008;(on line)
  16. Verpoort KN, Papendrecht-van der Voort EAM, van der Helm-van Mil AHM, et al. Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLA-DRB1 shared epitopes alleles. Arthritis and Rheumatism. 2007;56:2913–2918
  17. Padyukov L, Silva C, Stolt P, et al. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis and Rheumatism. 2004;50:3085–3092
  18. Linn-Rasker SP, van der Helm-van Mil AHM, van Gaalen FA, et al. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Annals of the Rheumatic Diseases. 2006;65:366–371
  19. van der Helm-van Mil AHM, Verpoort KN, Le Cessie S, et al. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide. Arthritis and Rheumatism. 2007;56:425–432
  20. Chang SC, Costenhader KH, Laden F, et al. Geographic variation and the risk of rheumatoid arthritis in women. [abstract] Arthritis and Rheumatism. 2000;54(Suppl. 9):S349
  21. Goëb V, Dieudé P, Daveau R, et al. Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitopes alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis. Rheumatology. 2008;(on line)
  22. Costenbader KH, Chang SC, de Vivo I, et al. Genetic polymorphism in PTPN22, PADI-4 and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking. Arthritis Research & Therapy. 2008;10:R52
  23. Kokkonen H, Johansson M, Innala L, et al. The PTPN22 1858 C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern sweden. Arthritis Research & Therapy. 2007;9:R56
  24. Källberg H, Padyakov L, Plenge RM, et al. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22 and smoking in two subsets of rheumatoid arthritis. American Journal of Human Genetics. 2007;80:867–875
  25. Saag KG, Cerhan JR, Kolluri S, et al. Cigarette smoking and rheumatoid arthritis severity. Annals of the Rheumatic Diseases. 1997;56:463–469
  26. Turesson C, O'Fallon WM, Xrowson CS, et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Annals of the Rheumatic Diseases. 2003;62:722–727
  27. Mattey DL, Hutchinson Dawes PT, Nixon NB, et al. Smoking and disease activity severity in rheumatoid arthritis:association with polymorphism at the Glutathione S-Transferase M1 locus. Arthritis and Rheumatism. 2002;46:640–646
  28. Manfredsdottir VF, Vikingsdottir T, Jonsson T, et al. The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis. Rheumatology. 2006;45:734–740
  29. Westhoff G, Rau R, Zink A. Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse but they do not have more joint damage than nonsmokers of the same serological group. Rheumatology. 2008;47:849–854
  30. Finckh A, Dehler S, Costenhader KH, Gabay C. Cigarette smoking and radiographic progression in rheumatoid arthritis. Annals of the Rheumatic Diseases. 2007;66:1066–1071
  31. Harrison BJ, Silman AJ, Wiles NJ, et al. The association of cigarette smoking with disease outcome in patientsHi with early inflammatory polyarthritis. Arthritis and Rheumatism. 2001;44:323–330
  32. Wolfe F, Zwillich SH. The long-term outcome of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1600 patients with rheumatoid arthritis. Arthritis and Rheumatism. 1999;41:1072–1082
  33. Nyhall-Wahlin BM, Jacobsson LT, Petersson IF, Turesson C, Barfot Study Group . Smoking is a strong risk factor for rheumatoid nodules in early rheumatoid arthritis. Annals of the Rheumatic Diseases. 2006;65:601–606
  34. Mikuls TR, Hughes LB, Westfall AO, et al. Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis. Annals of the Rheumatic Diseases. 2008;(on line)
  35. Kim SK, Park SH, Shin IH, Choe JY. Anti-cyclic citrullinated peptide antibody, smoking, alcohol consumption and disease duration as risk factors for extraarticular manifestations in Korean patients with rheumatoid arthritis. The Journal of Rheumatology. 2008;35:995–1001
  36. Gochuico BR, Avila NA, Chow CK, et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Archives of Internal Medicine. 2008;168:159–166
  37. Farragher TM, Goodson NJ, Naseem H, et al. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis and Rheumatism. 2008;58:359–369
  38. Mattey DL, Thomson W, Ollier WE, et al. Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: results of eighteen years of follow-up from the early rheumatoid arthritis study. Arthritis and Rheumatism. 2007;56:1408–1416
  39. Hyrich KL, Watson KD, Silman AJ, Symmons DPM and the BSR Biologics Register. Rheumatology. 2006;45:1558–1565
  40. Klareskog L, Padyakov L, Alfredsson L. Smoking as a trigger for inflammatory rheumatic diseases. Current Opinion in Rheumatology. 2007;19:49–54
  41. Ghaussy NO, Sibbitt W, Bankhurst AD, Qualls CR. Cigarette smoking and disease activity in systemic lupus erythematosus. The Journal of Rheumatology. 2003;30:1215–1221
  42. Freiman A, Bird G, Metelitsa AI, et al. Cutaneous effects of smoking. Journal of Cutaneous Medicine and Surgery. 2004;8:415–423
  43. McAlindon T, Giannotta L, Taub N, et al. Environmental factors predicting nephritis in systemis lupus erythematosus. Annals of the Rheumatic Diseases. 1993;52:720–724
  44. Maurel A, Apovo M, Beuzard Y, et al. Effect of smoking on blood rheology. Journal des maladies vasculaires. 1997;22:239–243
  45. Verro P, Levine SR, Tietjen GE. Cerebrovascular ischemic events with high positive anticardiolipin antibodies. Stroke. 1998;29:2245–2253
  46. Sairam S, Baethge BA, McNearney T. Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies. Clinical Rheumatology. 2003;22:24–29
  47. Freemer MM, King TE, Criswell LA. Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 2006;65:581–584
  48. Wiencke JK, Thurston SW, Kelsey KT, et al. Early age at smoking initiation and tobacco carcinogen DNA damage in the lung. Journal of the National Cancer Institute. 1999;91:614–619
  49. Costenbader KH, Kim DJ, Peerzada J, et al. Cigarette smoking and the risk of sustemic lupus erythematosus: a meta-analysis. Arthritis and Rheumatism. 2004;50:849–857
  50. Ignat GP, Rat AC, Sychra JJ, et al. Information on diagnosis and management of systemic lupus erythematosus derived from the routine measurement of 8 nuclear autoantibodies. The Journal of Rheumatology. 2003;30:1761–1769
  51. Abu-Shakra M, Gladman DD, Urowitz MB. Malignancy in systemic lupus erythematosus. Arthritis and Rheumatism. 1996;39:1050–1054
  52. Sultan SM, Ioannou Y, Isenberg DA. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review. Rheumatology. 2000;39:1147–1152
  53. Bernatsky S, Boivin JF, Joseph L, et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis and Rheumatism. 2005;52:1481–1490
  54. Menon S, Snaith ML, Isenberg DA. The association of malignancy with SLE: an analysis of 150 patients under long-term review. Lupus. 1993;2:177–181
  55. Rahman P, Gladman DD, Urowitz MB. Smoking interferes with efficacy of antimalarial therapy in lupus. The Journal of Rheumatology. 1998;25:1716–1719
  56. Jewell ML, McCauliffe DP. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. Journal of the American Academy of Dermatology. 2000;42:983–987
  57. Lardet D, Martin S, Truchetet F, et al. Effect of smoking on the effectiveness of antimalarial drugs on lesions of patients with lupus: assessment in a prospective study. La Revue de médecine interne. 2004;25:786–791

PII: S1521-6942(08)00107-1

doi: 10.1016/j.berh.2008.09.011

Best Practice & Research Clinical Rheumatology
Volume 22, Issue 5 , Pages 923-935 , October 2008

Article Tools

* Image Usage & Resolution